VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, 94304-1207, United States
NCT Number: NCT07741955
Cardiovascular disease is the leading cause of death among Veterans. Clinical trials are essential for developing better treatments, but Veterans remain underrepresented in these studies due to barriers including limited health literacy, lack of awareness, and mistrust. Current outreach approaches rely on either in-person physician conversations, which are limited by workforce constraints, or mailed letter invitations, which often fail to engage Veterans with limited health literacy. This study tests whether AI-generated video avatars can improve Veteran engagement in cardiovascular clinical trials.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Palo Alto, California, 94304-1207, United States
Recent advances in artificial intelligence now enable the creation of personalized video avatars at negligible cost and time. These computer-generated videos can be rapidly adapted to describe any clinical trial and tailored to individual patient preferences in both speaker appearance and content.
The EVERYVET Study (Empowering VEterans in Research effectivelY using Virtual Engagement Tools) will evaluate whether these AI-supported tools can increase Veteran engagement in cardiovascular clinical trials compared to standard mailed letter invitations. The avatar invitations will be randomly embedded into outgoing invitations for existing VA clinical studies. Veterans will be able to choose their preferred avatar speaker from a diverse set of computer-generated avatars and self-select the content topics most important to them. The study is co-designed with the Veterans and Family Research Engagement Council (VFREC) and a Veteran Co-Investigator to ensure the approach centers Veteran priorities and preferences throughout.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
Inclusion criteria
(Aim 1 Qualitative Interviews):
Inclusion criteria
(Aim 1 Beta-Testing and Aim 3):
Inclusion criteria
(Focus Groups):
Exclusion criteria
Exclusion criteria
Exclusion criteria
(Aim 1 Qualitative Interviews):
Exclusion criteria
(Aim 1 Beta-Testing and Aim 3):
Veterans randomized to the intervention arm will receive the website link where they can select their preferred avatar speaker(s) from a diverse set of options and self-select content topics of interest. They may watch the self-directed tailored video to guide their decision to participate in the parent trial.
Other names: AI-Supported Patient Engagement Tool
Time frame: Baseline through 6 months
Superiority of enrollment rate in the intervention arm (AI-supported avatar invitation) compared to the control arm (routine letter invitation alone), assessed using an intention-to-treat approach.
Time frame: Baseline through 6 months
Process measure assessing engagement with the QR code and URL among Veterans randomized to the intervention arm.
Time frame: Baseline through 6 months
Process measure assessing video viewing behavior tracked through unique de-identified research numbers.
Time frame: Baseline through 6 months
Frequency distribution of avatar speaker selections among Veterans who accessed the website
Trial opening soon.
Get NotifiedVA Office of Research and Development
Fed
EVERYVET (Empowering VEterans in Research effectivelY Using Virtual Engagement Tools): A Patient-Centered Study
Acronym: EVERYVET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07595068
Arrhythmias, Cardiac, Atrial Fibrillation
Huangshi, Hubei, China
View Trial DetailsNCT07077811
Arrhythmias, Cardiac, Atrial Fibrillation
Nantong, Jiangsu, China
View Trial DetailsNCT06796582
Arrhythmias, Cardiac, Arterial Hypertension
View Trial DetailsNCT06728826
Arrhythmias, Cardiac, Atrial Fibrillation
Shanghai, China
View Trial Details